SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Acutaas Chemicals - Quaterly Results

01 May 2026 Evaluate
The sales surged to Rs. 4217.72 millions, up 38.67% for the March 2026 quarter as against Rs. 3041.61 millions during the corresponding quarter previous year.The Net Profit of the company vaulted to 118.10% to Rs. 1370.71  millions from Rs. 628.48 millions in the previous quarter.Operating Profit saw a handsome growth to 1957.63 millions from 897.52 millions in the quarter ended March 2026.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 4217.72 3041.61 38.67 13237.92 9898.35 33.74 13237.92 9898.35 33.74
Other Income 145.46 56.94 155.46 458.78 183.36 150.21 458.78 183.36 150.21
PBIDT 1957.63 897.52 118.12 5288.83 2434.78 117.22 5288.83 2434.78 117.22
Interest 10.72 3.83 179.90 30.77 58.57 -47.46 30.77 58.57 -47.46
PBDT 1946.91 893.69 117.85 5258.06 2376.21 121.28 5258.06 2376.21 121.28
Depreciation 88.30 65.56 34.69 330.32 240.45 37.38 330.32 240.45 37.38
PBT 1858.61 828.13 124.43 4927.74 2135.76 130.73 4927.74 2135.76 130.73
TAX 487.90 199.65 144.38 1265.99 540.29 134.32 1265.99 540.29 134.32
Deferred Tax 17.36 47.36 -63.34 111.09 70.58 57.40 111.09 70.58 57.40
PAT 1370.71 628.48 118.10 3661.75 1595.47 129.51 3661.75 1595.47 129.51
Equity 409.36 409.34 0.00 409.36 409.34 0.00 409.36 409.34 0.00
PBIDTM(%) 46.41 29.51 57.29 39.95 24.60 62.42 39.95 24.60 62.42

Acutaas Chemicals Share Price

2675.10 78.55 (3.03%)
04-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1824.10
Dr. Reddys Lab 1287.95
Cipla 1334.85
Zydus Lifesciences 901.65
Lupin 2350.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×